Condition: Aortic Valve Disease · Ascending Aorta Abnormality · Aortic Dissection · Sponsor: Abbott Medical Devices
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
This description comes directly from the study's public registry record.
Paolo Amato · +39 335 61 40 573 · paolo.amato@abbott.com
Karine Miquel · +32 479 60 01 07 · karine.miquel@abbott.com
Always discuss trial participation with your own doctor first.
| University Hospital - Univ. of Alabama at Birmingham (UAB) | Birmingham, Alabama, United States | Withdrawn |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Mission Health & Hospitals | Asheville, North Carolina, United States | Withdrawn |
| Hospital of the University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| Klinik Floridsdorf | Vienna, Austria | Recruiting |
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| CHU de Besancon - Jean Minjoz | Besançon, France | Recruiting |
| CHRU Lille | Lille, France | Recruiting |
| Groupe Hospitalier Bichat - Claude Bernard | Paris, France | Recruiting |
| Herz-und Diabetes Zentrum NRW | Bad Oeynhausen, Germany | Recruiting |
| Deutsches Herzzentrum Berlin | Berlin, Germany | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04754217